Evidence map›Paper›PMID 34060470›Full record

ArticleeLife2021

Traumatic injury compromises nucleocytoplasmic transport and leads to TDP-43 pathology.

Eric N Anderson, Andrés A Morera, Sukhleen Kour, Jonathan D Cherry, Nandini Ramesh, Amanda Gleixner, Jacob C Schwartz, Christopher Ebmeier, William Old, Christopher J Donnelly and 5 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. TDP-43: unveiling the hidden key to cellular fate decisions.Cell communication and signaling : CCS · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Nuclear transport proteins: structure, function, and disease relevance.Signal transduction and targeted therapy · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Eric N AndersonDepartment of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, United States.
Andrés A MoreraDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, United States.
Sukhleen KourDepartment of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, United States.
Jonathan D CherryDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, United States.
Nandini RameshDepartment of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, United States.
Amanda GleixnerDepartment of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, United States.
Jacob C SchwartzDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, United States.
Christopher EbmeierMolecular, Cellular & Developmental Biology, University of Colorado, Boulder, United States.ORCID 0000-0001-7940-6190
William OldMolecular, Cellular & Developmental Biology, University of Colorado, Boulder, United States.
Christopher J DonnellyDepartment of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, United States.ORCID 0000-0002-2383-9015
Jeffrey P ChengPhysical Medicine & Rehabilitation; Safar Center for Resuscitation Research, University of Pittsburgh, Pittsburgh, United States.
Anthony E KlinePhysical Medicine & Rehabilitation; Safar Center for Resuscitation Research, University of Pittsburgh, Pittsburgh, United States.
Julia KoflerDepartment of Pathology, University of Pittsburgh, Pittsburgh, United States.
Thor D SteinDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, United States.
Udai Bhan PandeyDepartment of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, United States.ORCID 0000-0002-6267-0179
University of Pittsburgh · USChildren's Hospital of Pittsburgh · USAllen Institute for Brain Science · USBoston University · USUniversity of Arizona · US

Funding

Traumatic Brain Injury and Repetitive Head Impacts: Contributions to AD/ADRD and CTE Neuropathology and Resulting Clinical SyndromesU54NS115266 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MCKEE, ANN C. · 2019 to 2023
$10.3M
Training in the Neurobiology of Neurological DiseaseT32NS086749 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Omar El Gharbawie, REBECCA P SEAL · 2014 to 2026
$4.8M
Optimizing Environmental Enrichment to Model Preclinical NeurorehabilitationR01NS084967 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLINE, ANTHONY E. · 2014 to 2025
$3.7M
Cellular and Molecular Mechanisms of FUS-related Amyotrophic Lateral SclerosisR01NS081303 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PANDEY, UDAI B · 2013 to 2023
$3.6M
Analysis of the RNA-binding Protein FUS and Its Role in Neurodegenerative DiseaseR00NS082376 · NINDS · UNIVERSITY OF ARIZONA · PI SCHWARTZ, JACOB C. · 2015 to 2017
$771k
Intranasal delivery of neural stem cells alone or in combination with environmental enrichment as a potential therapy for experimental TBIR56NS113810 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GUTOVA, MARGARITA, KLINE, ANTHONY E. · 2020 to 2020
$430k
Nuclear export inhibition as a novel therapeutic target for C9ORF72 ALS/FTDR21NS098379 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DONNELLY, CHRISTOPHER JAMES, PANDEY, UDAI B · 2017 to 2018
$429k
Oligonucleotide approach to antagonize neurotoxic TDP-43 assemblies in dementiaR21AG064940 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DONNELLY, CHRISTOPHER JAMES, PANDEY, UDAI B · 2019 to 2020
$417k
NIA NIH HHS R21 AG064940NINDS NIH HHS R00 NS082376NINDS NIH HHS R01 NS081303NINDS NIH HHS R01 NS084967NINDS NIH HHS R21 NS098379NINDS NIH HHS R56 NS113810NINDS NIH HHS U54 NS115266
6 · The paper itself

Abstract

Traumatic brain injury (TBI) is a predisposing factor for many neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), Parkinson's disease (PD), and chronic traumatic encephalopathy (CTE). Although defects in nucleocytoplasmic transport (NCT) is reported ALS and other neurodegenerative diseases, whether defects in NCT occur in TBI remains unknown. We performed proteomic analysis on

Indexed as

Active Transport, Cell NucleusAnimalsAnimals, Genetically ModifiedBrainBrain Injuries, TraumaticCase-Control StudiesDisease Models, AnimalDNA-Binding ProteinsDrosophila melanogasterDrosophila ProteinsGTPase-Activating ProteinsHEK293 CellsHumansLongevityMaleMembrane GlycoproteinsDNA-Binding ProteinsDrosophila ProteinsGTPase-Activating ProteinsMembrane GlycoproteinsNuclear Pore Complex Proteinsnuclear pore protein p62Nup214 protein, DrosophilaProtein AggregatesRanGAP protein, DrosophilaTARDBP protein, humanTardbp protein, ratTBPH protein, Drosophilaamyotrophic lateral sclerosischronic traumatic encephalopathyD. melanogastergeneticsgenomicshumanneurodegenerationneuroscienceratTDP-43

Identifiers

PMID34060470
PMCPMC8169113
OpenAlexW3164522752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.